| 199982-72-4 | Vlv85gwl2N | C14H16O2 |
| 351427-18-4 | Vitetrifolin D | C24H38O5 |
| 714950-70-6 | Vilazodone metabolite M13 | C26H27N5O3 |
| 348089-57-6 | VD2Dmr29U5 | C20H30N8O |
| 1197333-70-2 | VER-3323 hemifumarate salt | C26H34Br2N4O4 |
| 1396980-34-9 | Valine, N-[2-(4-chloro-2-methylphenoxy)-1-oxopropyl]- | C15H20ClNO4 |
| 238401-16-6 | Valiloxibic acid | C9H17NO4 |
| 1259372-69-4 | VU 0155041 Sodium salt | C14H14Cl2NNaO3 |
| 1293489-77-6 | Vortioxetine Impurity 4 | C18H22N2S |
| 1233937-39-7 | Vitamin K1-d7 | C31H46O2 |
| 1217627-44-5 | Valnemulin Trifluoroacetic Acid Salt-d6 | C31H52N2O5S |
| 1309976-62-2 | VU 0360172 hydrochloride | C18H16ClFN2O |
| 1240670-85-2 | Vortioxetine Impurity 14 | C28H34N4S |
| 1111177-30-0 | Valsartan Ethyl Ester | C26H33N5O3 |
| 1391054-02-6 | Vigabatrin Hydrochloride | C6H12ClNO2 |
| 149153-08-2 | Vitamin C-6-13C | C6H8O6 |
| 158180-04-2 | Vitamin D3 Decanoate (>90%) | C37H62O2 |
| 338992-53-3 | Vandetanib trifluoroacetate | C24H25BrF4N4O4 |
| 30707-88-1 | Vanadium oxide tris(methoxyethoxide) | C9H24O7V |
| 524722-52-9 | Vandetanib hydrochloride | C22H25BrClFN4O2 |
| 725232-44-0 | Vialox Peptide(Pentapeptide-3) diacetate | C25H45N9O9 |
| 1397001-07-8 | Valine, N-[2-[(4-methoxybenzoyl)amino]benzoyl]-, 2-[2-(2-benzothiazolylthio)acetyl]hydrazide | C29H29N5O5S2 |
| 1256639-86-7 | Vyxeos | C36H42N4O15 |
| 887258-95-9 | Vabicaserin | C15H20N2 |
| 805240-76-0 | Vex3BL2H9X | C23H27Cl2N3O6S |
| 866933-51-9 | Velusetrag hydrochloride | C25H37ClN4O5S |
| 60250-35-3 | Vst39HM4ML | C5H10N2O |
| 10578-09-3 | Vinylbenzylamine | C9H11N |
| 4206-62-6 | Vinylbenzylamine hydrochloride | C9H12ClN |
| 57819-22-4 | V5X6XQ6PJ4 | C6H9NO5 |
| 135384-01-9 | Vqsyqfikiculrp-huucewrrsa- | C17H33NO3 |
| 914468-29-4 | Vermelhotin | C12H11NO3 |
| 180580-73-8 | Vitisin C | C56H42O12 |
| 328073-92-3 | VEGF Inducer, GS4012 | C14H16ClNOS |
| 946161-17-7 | Volasertib trihydrochloride | C34H53Cl3N8O3 |
| 1791404-50-6 | Vilazodone metabolite M17 | C13H12N2O2 |